Compared to Estimates, Dick's (DKS) Q1 Earnings: A Look at Key Metrics — Positive

DKS   Zacks Investment Research — May 28, 2025

Although the revenue and EPS for Dick's (DKS) give a sense of how its business performed in the quarter ended April 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

image for news Compared to Estimates, Dick's (DKS) Q1 Earnings: A Look at Key Metrics

Is It Worth Investing in New Gold (NGD) Based on Wall Street's Bullish Views? — Positive

NGD   Zacks Investment Research — May 28, 2025

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

image for news Is It Worth Investing in New Gold (NGD) Based on Wall Street's Bullish Views?

Wall Street Analysts Think Chipotle (CMG) Is a Good Investment: Is It? — Positive

CMG   Zacks Investment Research — May 28, 2025

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

image for news Wall Street Analysts Think Chipotle (CMG) Is a Good Investment: Is It?

Report Illustrates How Tech-Savvy Organizations Are Gaining a Competitive Edge in the Age of AI CHARLESTON, S.C. , May 28, 2025 /PRNewswire/ -- The Blackbaud Institute, a research lab at Blackbaud (NASDAQ: BLKB), the leading provider of software for powering social impact, today released a new report, The Status of Fundraising in the AI Era.

image for news New Report from the Blackbaud Institute Shows Clear Link Between Social Impact Organizations' Tech Use and Fundraising Revenue Growth

Buy The Dip: 2 Blue-Chip 9%+ Yields Getting Way Too Cheap — Positive

COP  FANG  LYB  PAA  PAGP   Seeking Alpha — May 28, 2025

It is rare to find 9%+ yielding dividend growth stocks that would qualify as blue chips. However, today, Mr. Market is offering several of them. We share two that are attractive buys on the dip.

image for news Buy The Dip: 2 Blue-Chip 9%+ Yields Getting Way Too Cheap

Trade Desk's Kokai Blip Is Already In The Rearview Mirror — Positive

TTD   Seeking Alpha — May 28, 2025

Kokai platform transition is complete, delivering significant cost and performance improvements for clients, and accelerating customer adoption beyond expectations. AI-driven enhancements, OpenPath, and retail media initiatives are fueling broad-based growth, with CTV as the largest and fastest-growing channel. The Trade Desk is gaining share as walled gardens face regulatory headwinds, and its independent, objective model is increasingly valued by advertisers and retailers.

image for news Trade Desk's Kokai Blip Is Already In The Rearview Mirror

Orasure Technologies: Multiple Shots To Deliver Value — Positive

OSUR   Seeking Alpha — May 28, 2025

OSUR remains deeply undervalued, trading below liquidation value, with a robust, cash-rich, debt-free balance sheet providing downside protection. Key value drivers include a 20% share buyback, potential building sale, and new product launches both in-house and via partnerships. Operational improvements—cost reductions, automation, and product diversification—should support gross margins and future growth.

image for news Orasure Technologies: Multiple Shots To Deliver Value

Abbott Stock Gains Following FDA Approval of the Tendyne System — Positive

ABT   Zacks Investment Research — May 28, 2025

ABT wins FDA approval for its Tendyne TMVR system, offering a minimally invasive mitral valve replacement for high-risk patients with severe MAC.

image for news Abbott Stock Gains Following FDA Approval of the Tendyne System

Eli Lilly vs. AstraZeneca: Which Pharma Powerhouse is the Better Buy? — Positive

AZN  LLY   Zacks Investment Research — May 28, 2025

Lilly dominates GLP-1 market but faces near-term headwinds, while AstraZeneca boasts steady growth, rising estimates and a higher dividend yield.

image for news Eli Lilly vs. AstraZeneca: Which Pharma Powerhouse is the Better Buy?

Salesforce's AI Push Grows With Informatica: Time to Hold the Stock? — Negative

CRM   Zacks Investment Research — May 28, 2025

CRM's $8 billion Informatica buyout move sharpens AI focus, supporting a hold rating amid soft revenue growth and underperforming stock.

image for news Salesforce's AI Push Grows With Informatica: Time to Hold the Stock?

NEW YORK, NY / ACCESS Newswire / May 28, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of UroGen Pharma Ltd. ("UroGen Pharma Ltd.

image for news Levi & Korsinsky Investigating Whether UroGen Pharma Ltd. (URGN) Misled Investors - Securities Law Violations Possible

SAN DIEGO , May 28, 2025 /PRNewswire/ -- Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in shares of The Bancorp, Inc. (NASDAQ: TBBK). Investors who purchased shares of The Bancorp, Inc. (NASDAQ: TBBK) prior to February 2024 and continue to hold any of those NASDAQ: TBBK shares also have certain options and contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554.

image for news Lawsuit for Investors in shares of The Bancorp, Inc. (NASDAQ: TBBK) announced by the Shareholders Foundation

NEW YORK, NY / ACCESS Newswire / May 28, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Meta Platforms, Inc. ("Meta Platforms, Inc.") (NASDAQ:META) concerning possible violations of federal securities laws. The Wall Street Journal published an article on May 15, 2025, entitled "Meta Is Delaying the Rollout of Its Flagship AI Model.

image for news Protect Your Investment: Contact Levi & Korsinsky About the Meta Platforms, Inc. (META) Investigation

ARLINGTON, Va., May 28, 2025 (GLOBE NEWSWIRE) -- Fluence Energy, Inc. (“Fluence”) (Nasdaq: FLNC), a global market leader delivering intelligent energy storage systems, operational services, and asset optimization software, welcomed U.S. Senator John Curtis (R-UT) to the Utah-based manufacturing facility that is producing Fluence's battery modules. The visit spotlighted Fluence's growing investment in U.S.-based manufacturing and its leadership in building a resilient domestic supply chain for battery energy storage solutions that has been accelerated by the availability of federal tax credits that directly support manufacturing in the United States.

image for news U.S. Senator John Curtis Visits Utah Manufacturing Facility Producing Fluence Battery Modules; Highlights Energy Jobs and Domestic Battery Supply Chain

MITER Brands Wins H.B. Fuller's 2025 Customer Innovation Award — Neutral

FUL   Business Wire — May 28, 2025

HARRISBURG, Pa.--(BUSINESS WIRE)--MITER Brands, a leading manufacturer of residential windows and patio doors, was named by H.B. Fuller Company (NYSE: FUL), the largest pureplay adhesives company in the world, as a winner of its 2025 Customer Innovation Awards. The awards honor forward-thinking customers whose innovations, powered by H.B. Fuller's adhesive technology, are setting new standards in sustainability, performance, and efficiency. MITER Brands received the award at H.B. Fuller's globa.

image for news MITER Brands Wins H.B. Fuller's 2025 Customer Innovation Award

Universal Health Services: Leveraging On Acute Hospital Care Growth — Positive

UHS   Seeking Alpha — May 28, 2025

I'm bullish on UHS due to strong acute care market growth, driven by rising chronic disease prevalence and robust healthcare spending. UHS's financials are impressive, with Q1'25 net income up 21% and revenue up 6.7%, reflecting sustained demand for acute care services. Valuation metrics show UHS is undervalued relative to peers, with a low P/S ratio and competitive revenue growth, supporting a buy rating.

image for news Universal Health Services: Leveraging On Acute Hospital Care Growth

Best Growth Stocks to Buy for May 28th — Positive

CRMT  STRT  SWX   Zacks Investment Research — May 28, 2025

STRT, SWX and CRMT made it to the Zacks Rank #1 (Strong Buy) growth stocks list on May 28, 2025.

image for news Best Growth Stocks to Buy for May 28th

ConocoPhillips Clears Key Hurdle Ahead of Australian Drilling Push — Negative

COP   Zacks Investment Research — May 28, 2025

COP wraps seabed surveys in Australia's Otway Basin, paving the way for 2025 drilling as KNOC joins its domestic gas exploration drive.

image for news ConocoPhillips Clears Key Hurdle Ahead of Australian Drilling Push

Eni Eyes Strategic Partnership With GIP in CCUS Business — Neutral

E   Zacks Investment Research — May 28, 2025

E enters exclusive talks to sell 49.99% of its CCUS unit to GIP, aiming to scale carbon projects in the UK, the Netherlands and Italy amid the EU climate push.

image for news Eni Eyes Strategic Partnership With GIP in CCUS Business

Custom AI Silicon, Data Center Boom Likely to Propel MRVL Q1 Earnings — Positive

MRVL   Zacks Investment Research — May 28, 2025

Marvell Technology's Q1 results are likely to reflect the benefits of strong traction in custom AI silicon and data center end markets.

image for news Custom AI Silicon, Data Center Boom Likely to Propel MRVL Q1 Earnings